Navigation Links
Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI's Biotech/Pharma Finance and Accounting Forum in San Francisco
Date:10/7/2009

BOSTON, Oct. 7 /PRNewswire/ -- The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce the full agenda for the upcoming Biotech/Pharma Finance and Accounting Forum in San Francisco on November 19, 2009. Marc J. Fagel, Regional Director of the San Francisco Regional Office at the U.S. Securities and Exchange Commission, is the most recent addition to the program's elite faculty and will address SEC enforcement and the review process.

This comprehensive one-day forum delves into the accounting and biotech financial reporting issues that matter most during these tough economic times and, in addition to the SEC, will include presentations from firms such as Cell Genesys, Affymax, BioMarin Pharmaceuticals, Monogram Biosciences, Inc., Oncomed and Poniard Pharmaceuticals. Over 2,400 executives have attended CBI's Pharmaceutical Accounting and Financial Reporting Congress since its inception more than five years ago, and this year's San Francisco program has been specifically designed for innovative life science companies.

Other opportune session topics include:

  • Taking the Pulse on the Economy and Chief Financial Challenges/Opportunities for Today's Biotech Companies
  • Wall Street Address: Creating Value and Securing Capital for Life Science Companies in a Strained Economy
  • Collaborative R&D Deals, Revenue Recognition and Accounting for Multiple Arrangements - Update on EITFs 08-1, 08-9 and 00-21
  • CFO Strategies and Capital Raising in a Tough Economy

CBI's west coast forum is sponsored by PricewaterhouseCoopers, Duff & Phelps, OUM & Co LLP and KPMG. To view the full agenda, please visit http://www.cbinet.com/agendawest. If you would like to apply for a press pass, please contact Erica Kirwan of CBI at 339.298.2263.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE The Center for Business Intelligence


'/>"/>
SOURCE The Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
2. NuVasive to Present at the JMP Securities Healthcare Focus Conference
3. InterMune to Present at JMP Securities Conference
4. NeurogesX to Present at JMP Securities Healthcare Focus Conference
5. Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
6. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
7. BioCryst to Present at JMP Securities Healthcare Conference
8. Researcher Investigates Disparities in Doctor-Patient Information Exchange During Clinical Trial Offers
9. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
10. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
11. D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the "Deep ... to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 report examines ... deep learning solutions within the healthcare domain. Primarily driven by the ... solution to generate relevant insights from medical data. ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and Rest ... through 2022. Also, a six-year historic analysis is provided for these markets. ...
(Date:3/24/2017)... Wash. , March 23, 2017  Mirabilis ... of advanced medical technology for non-invasive surgery, announced ... Mirabilis System for treatment of uterine fibroids throughout ... it had received approval from the US Food ... of the Mirabilis System in the United States.  ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... ... 2017 , ... Judy Buchanan, co-owner of Serenity Natural Health ... says, “I am passionate about sharing Reiki as a holistic, complementary therapy with ... time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical Reiki™ ...
(Date:3/24/2017)... ... ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous ... the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks at ... her passion for writing, especially about truth and human behavior. , Published by Christian ...
(Date:3/23/2017)... ... 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased to ... 2. The clinic is the group’s second in New Braunfels and 22nd in Texas. ... New Braunfels location brings things full circle for the group, “It’s crazy to think ...
Breaking Medicine News(10 mins):